- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Solid Tumors or Triple-negative Breast Cancer
Total 1896 results
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
HutchmedActive, not recruitingRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast CarcinomaUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
Merrimack PharmaceuticalsCompletedColorectal Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Squamous Cell Head and Neck CancerUnited States
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
AkesoRecruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast CancerChina
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
Institut Claudius RegaudActive, not recruitingTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
Melinda TelliPfizer; BioMarin PharmaceuticalCompletedAdvanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast CancerUnited States
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingAdvanced Triple Negative Breast CancerChina
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
Laekna LimitedCompletedSolid Tumor | TNBC - Triple-Negative Breast CancerChina
-
Fujian Cancer HospitalNot yet recruitingAdvanced Triple Negative Breast CancerChina
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Melanoma | Triple-Negative Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Peptomyc S.L.TerminatedPancreatic Cancer | Advanced Solid Tumors | CRCSpain
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
pharmaand GmbHGilead SciencesTerminatedOvarian Cancer | Solid Tumor | Urothelial Carcinoma | Triple-negative Breast CancerUnited States
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast TripleUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
ChimerixWithdrawnAdvanced Colorectal Cancer | Advanced Glioblastoma | Advanced Triple-negative Breast Cancer | Advanced Non-small Cell Lung CancerUnited States
-
CytosinLab Therapeutics Co., Ltd.RecruitingPancreatic Cancer | Non-small Cell Lung Cancer | Solid Tumors | Triple-negative Breast CancerChina
-
Curis, Inc.CompletedHigh-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline CarcinomaUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
National Cancer Institute (NCI)SuspendedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Hummingbird BioscienceMerck Sharp & Dohme LLCRecruitingCancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Nonsmall Cell Lung Cancer | Malignant Neoplasm | Tumor, SolidUnited States
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Peregrine PharmaceuticalsWithdrawnBreast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune...TerminatedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | TNBC - Triple-Negative Breast Cancer | Triple-negative Breast CarcinomaUnited States
-
Eisai Co., Ltd.CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast CancerChina
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingEGFR/ B7H3-positive Advanced Lung Cancer | EGFR/ B7H3-positive Advanced Triple-negative Breast CancerChina